Literature DB >> 2580092

Significance of antikeratin antibodies in rheumatoid arthritis.

V J Hajiroussou, J Skingle, A P Gillett, M Webley.   

Abstract

Antikeratin antibodies (AKA) were found in the sera of 59% (121/204) of patients with rheumatoid arthritis (RA). There was a significantly higher incidence of AKA (73%) in male patients compared with females (53%) and a correlation between AKA positivity and IgM rheumatoid factor was found. Antibody reactivity was positively associated with the presence of nodules, antinuclear antibody, C-reactive protein and disease severity. AKA would appear to have possible prognostic significance in patients with RA.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2580092

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  10 in total

1.  The rheumatoid arthritis-associated autoantibodies to filaggrin label the fibrous matrix of the cornified cells but not the profilaggrin-containing keratohyalin granules in human epidermis.

Authors:  M Simon; C Vincent; M Haftek; E Girbal; M Sebbag; V Gomès-Daudrix; G Serre
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

2.  The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.

Authors:  M Sebbag; M Simon; C Vincent; C Masson-Bessière; E Girbal; J J Durieux; G Serre
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

3.  The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.

Authors:  M Simon; E Girbal; M Sebbag; V Gomès-Daudrix; C Vincent; G Salama; G Serre
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

4.  Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis.

Authors:  L Vasiliauskiene; A Wiik; M Høier-Madsen
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

5.  Lack of antikeratin antibodies in patients with palmoplantar pustular eruptions and arthropathy.

Authors:  A G Jurik; H Graudal; H Kirstein
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

6.  Subclass distribution of IgG antibodies to the rat oesophagus stratum corneum (so-called anti-keratin antibodies) in rheumatoid arthritis.

Authors:  C Vincent; G Serre; J P Basile; H C Lestra; E Girbal; M Sebbag; J P Soleilhavoup
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

7.  Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides.

Authors:  C Vincent; F de Keyser; C Masson-Bessière; M Sebbag; E M Veys; G Serre
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

8.  Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis.

Authors:  C Gabay; A M Prieur; O Meyer
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

9.  Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis.

Authors:  L Paimela; M Gripenberg; P Kurki; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

10.  Immunoblotting detection of so-called 'antikeratin antibodies': a new assay for the diagnosis of rheumatoid arthritis.

Authors:  V Gomès-Daudrix; M Sebbag; E Girbal; C Vincent; M Simon; J Rakotoarivony; M Abbal; B Fournié; G Serre
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.